ライフサイエンスコーパス: recombinant fusion protein

1 e and threonine residues when expressed as a recombinant fusion protein.

2 -1 using anti-human Dectin-1 (hDectin-1)-HA1 recombinant fusion proteins.

3 e simultaneously identifying catabolites for recombinant fusion proteins.

4 livery problem is the genetic engineering of recombinant fusion proteins.

5 gy for the removal of the affinity tags from recombinant fusion proteins.

6 ommercial proteases commonly used to process recombinant fusion proteins.

7 ors, and nine were successfully expressed as recombinant fusion proteins.

8 ed together in "pull-down" experiments using recombinant fusion proteins.

9 with CSP and by protein binding assays using recombinant fusion proteins.

10 o prokaryotic expression vectors to generate recombinant fusion proteins.

11 the D2 receptor was confirmed in vitro using recombinant fusion proteins.

12 es, Pfs25 and Pfs28, were produced as single recombinant fusion proteins.

13 as employed for high level expression of the recombinant fusion proteins.

14 o pMalcRI and pGEX vectors for expression as recombinant fusion proteins.

15 We used human recombinant fusion proteins 70 kd, B, and D to stimulate

16 allergen-unrelated carrier in the form of a recombinant fusion protein and used for sensitization.

17 Using recombinant fusion proteins and a blot overlay assay, we

18 ed by an in vitro biochemical assay by using recombinant fusion proteins and by co-immunoprecipitatio

19 G autoantibody were stimulated with an hnRNP recombinant fusion protein, and the cells were cloned by

20 n the immunogenicity of vaccination with the recombinant fusion protein Ay-Ancylostoma-secreted prote

21 ing cells, that were activated in vitro with recombinant fusion protein BA7072.

22 Polyvalent antibody responses to a recombinant fusion protein based on the HGE agent groEL

23 tem has been developed for the separation of recombinant fusion proteins based on the Ca(2+)-dependen

24 In the present study, recombinant fusion proteins bearing the 12 amino acid me

25 As therapeutic recombinant fusion proteins become more widely applicabl

26 of patients with hemophilia A. rFVIIIFc is a recombinant fusion protein composed of a single molecule

27 rFIXFc is a recombinant fusion protein composed of FIX and the Fc do

28 Alefacept, an immunomodulatory recombinant fusion protein composed of the first extrace

29 Hence, full-length ACII, ACIX, and recombinant fusion proteins composed of the cytoplasmic

30 Here we describe the development of a recombinant fusion protein comprised of a cowpox virus e

31 Here, we describe the development of a recombinant fusion protein comprised of SDF1 and an elas

32 neuropil was also seen after injection of a recombinant fusion protein comprised of TTC linked to th

33 responding to different regions of TrkB or a recombinant fusion protein comprising part of the extrac

34 The antibody was directed against a recombinant fusion protein consisting of a 70-amino-acid

35 This is a recombinant fusion protein consisting of a mutated varia

36 logous dendritic cells loaded ex vivo with a recombinant fusion protein consisting of prostatic acid

37 sites of complement activation and disease, recombinant fusion proteins consisting of a complement i

38 A recombinant fusion protein, consisting of the extracellu

39 Structural studies of recombinant fusion protein constructs yielded identifica

40 identification of the site, we constructed a recombinant fusion protein containing 334 amino acids of

41 Mice were immunized with a recombinant fusion protein containing Pca1.

42 e monoclonal antibodies were produced with a recombinant fusion protein containing RAP-1(1-294).

43 ere eliminated by previous incubation with a recombinant fusion protein containing the KC antigenic s

44 , we describe the high-level expression of a recombinant fusion protein containing the serine-rich En

45 e hepatitis B surface protein, PreS, in four recombinant fusion proteins containing different numbers

46 We generated recombinant fusion proteins containing the TAT protein t

47 Immunoblots of a recombinant fusion protein corresponding to this ORF sup

48 A recombinant fusion protein (DB fusion) was created by jo

49 astasis by a soluble form of E-selectin, the recombinant fusion protein E-selectin-immunoglobulin.

50 recently cloned Ag2 cDNA and showed that the recombinant fusion protein elicited strong delayed-type

51 n-transgenic cells could be reproduced using recombinant fusion proteins encoding non-overlapping reg

52 es when probed by immunoblotting against the recombinant fusion protein expressed from the pML-MIT3 c

53 In this report, we took advantage of a recombinant fusion protein for OGDC-E2 to address these

54 w by flow cytometric analysis that a soluble recombinant fusion protein (FP29), representing the abun

55 In this study, we produced an additional recombinant fusion protein from the NC1 domain correspon

56 the hepatitis B virus-derived PreS domain as recombinant fusion proteins (i.e., PreS-2XP4P5 and PreS-

57 against a synthetic peptide called LB1 or a recombinant fusion protein immunogen [LPD-LB1(f)(2,1,3)]

58 When expressed as a recombinant fusion protein in bacteria, APP-1 bound spec

59 MT2 was also expressed as a recombinant fusion protein in Escherichia coli, purified

60 owed significant reactivity against pML-MIT3 recombinant fusion protein in the ELISA assay.

61 TLA-4Ig gene transfer is as effective as the recombinant fusion protein in treating established CIA,

62 ped a novel pretargeting strategy exploiting recombinant fusion proteins in which a soluble form of T

63 The purified recombinant fusion protein is active and was used to par

64 A recombinant fusion protein linking coagulation factor IX

65 3 study, demonstrate efficacy and safety of recombinant fusion protein linking coagulation factor IX

66 Binding of the recombinant fusion protein MBP-YL37a was to domains II a

67 Treatment of ApoE(-/-) mice with a dimeric recombinant fusion protein, mGremlin1-Fc, but not with e

68 The over-expressed recombinant fusion protein (minus the transitpeptide) sh

69 Systemic administration of soluble recombinant fusion protein of cytotoxic T lymphocyte ant

70 Denileukin diftitox (Ontak), a recombinant fusion protein of diphtheria toxin and ligan

71 ents with PBC, 152 sera (81.7%) reacted with recombinant fusion protein of PDC-E2, whereas 171 sera (

72 rbent assay (ELISA), using affinity-purified recombinant fusion protein of pML-MIT3 clone as the anti

73 roducts obtained from the tPA treatment on a recombinant fusion protein of the amino-terminal domain

74 intranasally immunized groups of mice with a recombinant fusion protein of Yersinia pestis F1 and Lcr

75 nfluenza hemagglutinin Ags to skin LCs using recombinant fusion proteins of anti-Langerin Ab and Ags

76 Catalytically active, recombinant fusion proteins of bacteriophage E endosiali

77 Recombinant fusion proteins of flagellin and antigens ha

78 the structure/function relationships of Emp, recombinant fusion proteins of full-length and truncated

79 Recombinant fusion proteins of PR can bind to in vitro t

80 uncated mutant) phosphorylated and activated recombinant fusion proteins of the mammalian MAP kinase

81 connective tissue disease by using either a recombinant fusion protein or synthetic peptides.

82 is protein will be facilitated by the use of recombinant fusion proteins or peptides based on the HGE

83 nd important catabolite information for this recombinant fusion protein, providing valuable insight i

84 ibodies raised in rabbits immunized with the recombinant fusion proteins recognized parasite proteins

85 A recombinant fusion protein (rFIXFc) containing a single

86 The immunoreactive recombinant fusion proteins rP28 and rP30 have become av

87 The recombinant fusion protein showed reactivity with sera f

88 patients with PBC were preabsorbed with the recombinant fusion protein, such sera were depleted of r

89 titox (DD; DAB(389)-interleukin-2 [IL-2]), a recombinant fusion protein targeting IL-2 receptor-expre

90 aken together, we conclude that the Tf-based recombinant fusion protein technology represents a promi

91 d by treating the recipients with CTLA4Ig, a recombinant fusion protein that blocks B7-CD28 T cell co

92 y and efficacy of a novel TNF antagonist - a recombinant fusion protein that consists of the soluble

93 sess the safety and efficacy of atacicept, a recombinant fusion protein that suppresses B-cell functi

94 ic synthetic carriers, host blood cells, and recombinant fusion proteins that are activated preferent

95 ically performed using cell-free assays with recombinant fusion proteins that contain varying numbers

96 The recombinant fusion protein, thioredoxin-human FAS domain

97 Blocking TNF-alpha in vivo with the soluble recombinant fusion protein TNFR:Fc slowed disease progre

98 l patients developed immune responses to the recombinant fusion protein used to prepare Provenge, and

99 in encoded by blt 801 has been produced as a recombinant fusion protein using a bacterial expression

100 MAbs, we constructed a set of HMW1 and HMW2 recombinant fusion proteins using the pGEMEX vectors and

101 The model was used to evaluate a recombinant fusion protein vaccine consisting of the Yer

102 In vitro experiments using recombinant fusion proteins verify the authenticity of t

103 The purified recombinant fusion protein was cleaved with protease Fac

104 Maximum yield of soluble active recombinant fusion protein was obtained from cells harve

105 Maximum yield of soluble recombinant fusion protein was obtained from cells harve

106 The MAF-1 recombinant fusion protein was purified to exhibit obvio

107 The size of the recombinant fusion protein was similar to that of the pr

108 Using C-terminal truncations of MalE-FliC recombinant fusion proteins, we mapped antigenic activit

109 Antibody binding and scuPA activity of this recombinant fusion protein were on par with the parent m

110 These recombinant fusion proteins were expressed in Escherichi

111 lar proteins or elastin-like polypeptides as recombinant fusion proteins, which form "rod-coil" and "

112 fied to near homogeneity both alone and as a recombinant fusion protein with a PTD, derived from HIV-